VEGFA and neoplasm: Anti-angiogenesis inhibitors can also cause a temporary decrease in tumor hypoxia, as VEGF temporarily normalizes the function of tumor-associated vasculature by decreasing vascular permeability and restoring sustained pressure gradients, increasing O2 delivery and perfusion of cytotoxic agents to the tumor site [72].